Finnish-Chinese nanomedicine research shows potential for cancer treatment
Scientists from the University of Helsinki, Åbo Akademi University and Huazhong University of Science and Technology (China) have unearthed a pioneering anti-cancer nanomedicine for targeted chemotherapy.
The daily brief: 2 July 2019
All the daily Finnish business news that works: Redhill Games, Bittium, CupOfTherapy and Nokia subsidiary SAC Wireless make headlines.
Tick bite? Tezted knows if you need to worry
Ticks are a growing problem worldwide. These tiny creatures can carry a plethora of diseases which are easily left undiagnosed. This is why Finnish diagnostics startup Tezted is creating a buzz.
Finnish research develops respiratory test app
Scientists at the University of Oulu have developed a mobile respiratory measurement app that employs the sensors of a mobile phone to detect anomalies in a person’s breathing.
The daily brief: 12 June 2019
All the daily Finnish business news that works: Naava, Framery, inauguration of Nordics’ largest LNG terminal, and Google’s new tech training hub in Helsinki make headlines.
The daily brief: 29 May 2019
All the daily Finnish business news that works: NurseBuddy, YIT, Stora Enso and Angry Birds mini-golf course make headlines.
Biohit to butt out cigarettes in Indonesia
Finnish biotechnology company Biohit has found a distributor for its nicotine-free Acetium lozenge, an effective tool for smoking cessation, in Indonesia.
Finland is the happiest country in the world, again
The Global Happiness Report has ranked Finland in first place for the second year in a row.
Rent a Finn as your guide to happiness
Visit Finland’s new Rent a Finn initiative invites people from around the world to experience first-hand how to live in harmony with nature and self like a Finn.
Finnish medical expertise tackles diabetes
Crown CRO and Swedish company Sigrid Therapeutics have agreed to join forces to study prediabetes.
Meru Health’s digital therapy studied in California
Finnish company Meru Health’s app-based digital depression therapy programme will be evaluated by researchers at Stanford Medicine and VA Palo Alto Health Care System.